|
2022
|
Invention
|
Powders for inhalation and production process thereof. Pharmaceutical compositions in the form of... |
|
|
Invention
|
Carbamoselenoyl derivatives as anti-infective agents. 222 = H, alkyl, aryl, heteroaryl. and desig... |
|
|
Invention
|
Pharmaceutical compound for use in a therapeutic treatment of chronic hbv infection. Pharmacologi... |
|
|
Invention
|
A process and an apparatus for administering a predefined amount of a compound. A process for adm... |
|
2021
|
Invention
|
Surgical tool for abdominal suture. Surgical tool (100) for abdominal suture, comprising: an elon... |
|
2020
|
Invention
|
Production of antimicrobials from vegetable waste. The present invention relates to a process for... |
|
|
Invention
|
Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination.
New p... |
|
2018
|
Invention
|
Path planning method for computing optimal parking maneuvers for road vehicles and corresponding ... |
|
2017
|
Invention
|
Device for ocular administration of fluids.
Device for administering a fluid into a patient's co... |
|
|
Invention
|
Fluorescent nanovesicles, method for obtaining them and uses thereof. The invention provides a fl... |
|
|
Invention
|
Use of 2-oxo-2h-pyrrol-1(5h)-carboxamide derivatives as anti-hiv agents and process for the produ... |
|
2016
|
Invention
|
System and a relative method for detecting polluting substances using a remotely piloted vehicle ... |
|
|
Invention
|
A system and a relative method for detecting polluting substances using a remotely piloted vehicl... |
|
|
Invention
|
New amino acid sequences with microbicidal activity derived from naja atra cardiotoxin 1 (ctx-1).... |
|
|
Invention
|
Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa).
The present... |
|
|
Invention
|
Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase. Compounds and... |
|
2015
|
Invention
|
Pro-apoptotic anti-ng2/cspg4 antibodies and their uses for disease therapy.
The present inventio... |
|
|
Invention
|
Pro-apoptotic anti-ng2/cspg4 antibodies and their uses for disease therapy. The present invention... |
|
|
Invention
|
Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors. Describe... |
|
|
Invention
|
Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors. Described he... |
|
|
Invention
|
New mdr1 inhibitors for overcoming multidrug resistance.
New inhibitors of the activity of the m... |
|
|
Invention
|
New mdr1 inhibitors for overcoming multidrug resistance. New inhibitors of the activity of the mu... |
|
|
Invention
|
Composition for extenders for the long-term conservation of animal seminal material. A formulatio... |
|
|
Invention
|
Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments... |
|
2014
|
Invention
|
Meta-substituted biphenyl peripherally restricted faah inhibitors. The present invention provides... |
|
2013
|
Invention
|
Acid ceramidase inhibitors and their use as medicaments. The present invention concerns, in a fir... |
|
2012
|
Invention
|
Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa). The present ... |
|
|
Invention
|
Functionalized calixarene derivatives for cell transfection. The present invention relates to cal... |
|
|
Invention
|
Modular systems for the controlled release of a substance with space and time control. An innovat... |
|
|
Invention
|
Modular systems for the controlled release of a substance with space and time control.
An innova... |
|
2011
|
Invention
|
Use of a coordination complex or compound for the measurement of temperature. Use for measuring t... |
|
|
Invention
|
Peripherally restricted faah inhibitors. 6 is substituted or unsubstituted cyclohexyl; and the ph... |
|
|
Invention
|
Peripherally restricted faah inhibitors. Peripherally restricted inhibitors of fatty acid amide h... |
|
|
Invention
|
Derivatives of nicotinic acid n-oxide, their preparation and their use as inhibitors of enzyme 3-... |
|
2009
|
Invention
|
Irreversible egfr inhibitor compounds with antiproliferative activity. The invention concerns a d... |
|
2008
|
Invention
|
A drug powder for inhalation administration and a process thereof. A drug powder is described and... |
|
|
Invention
|
Device for the treatment of tinnitus.
A device for the treatment of tinnitus, comprising generat... |
|
2007
|
Invention
|
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-component... |
|
2006
|
Invention
|
Modules, new assemblage kits and new assembles for the controlled release of substances.
A modul... |
|
|
Invention
|
Method for conversion of uric acid to allantoin and related enzymes. A polypeptide molecule able ... |
